Skip to search formSkip to main contentSkip to account menu

Chromogranin A (344-364) fragment

Known as: catestatin, chromogranin A (344-364) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular activities. Conflicting results have been… 
2012
2012
New endogenous antimicrobial peptides (AMPs) derived from chromogranin A (CgA) are secreted by nervous, endocrine and immune… 
2011
2011
Screening patients with stage B heart failure(HF) may be one strategy for reducing human morbidity. To describe catestatin levels… 
2010
2010
BACKGROUND Obstructive sleep apnea (OSA) is common in children and leads to multiple end-organ morbidities induced by the… 
2010
2010
Catestatin is a natural peptide of higher organisms including humans, with a wide variety of biological functions involved in… 
Highly Cited
2009
Highly Cited
2009
We reported previously that chromogranin A (Chga) knockout (KO) mice are hypertensive and hyperadrenergic. Here we sought to… 
Highly Cited
2002
Highly Cited
2002
The catestatin fragment of chromogranin A is the first known endogenous compound able to inhibit catecholamine release elicited…